CEO: Simon Kerry

Advent Contact: Shahzad Malik

Addressing Undruggable Targets

Curve is a drug-discovery company focused on the development of innovative technologies to address currently undruggable disease-modifying targets, with an in-house focus on cancer.

Advent founded Curve in 2019

Back